Kinney Horn
Corporate Officer/Principal presso IMMUNOME, INC.
Patrimonio netto: 27 825 $ in data 31/03/2024
Profilo
Kinney Horn is currently the Chief Business Officer at Immunome, Inc. Prior to this, he held the position of Director-Business Development at Genentech, Inc. from 2003 to 2019.
He also served as the Chief Business Officer at Olema Pharmaceuticals, Inc. from 2020 to 2023.
Mr. Horn holds a graduate degree from Georgetown University and an undergraduate degree from the University of Mary Washington.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 01/02/2023 | 2 458 ( 0.00% ) | 27 825 $ | 31/03/2024 |
Posizioni attive di Kinney Horn
| Società | Posizione | Inizio |
|---|---|---|
| IMMUNOME, INC. | Corporate Officer/Principal | - |
Precedenti posizioni note di Kinney Horn
| Società | Posizione | Fine |
|---|---|---|
| OLEMA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 24/03/2023 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/04/2019 |
Formazione di Kinney Horn
| Georgetown University | Graduate Degree |
| University of Mary Washington | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| IMMUNOME, INC. | Health Technology |
| OLEMA PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Kinney Horn
